[1]
G. Gupta, A. S. Naidu, and P. Kumar, “Toxicities Profile of Bevacizumab in Cancer Patients Treated in a Tertiary Care Cancer Institute”, SRMsJMS, vol. 10, no. Suppl1, pp. S1-S4, Jun. 2025.